loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 212614 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Boehringer Ingelheim GmbH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BOEHRINGER INGELHEIM (4)

    filter

    01 TABLET, EXTENDED RELEASE;ORAL (4)

    filter

    01 RX (4)

    filter

    01 TRIJARDY XR (4)

    filter

    01 Yes (4)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    25MG;5MG;1GM
    2020-01-27
    212614
    TRIJARDY XR
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    10MG;5MG;1GM
    2020-01-27
    212614
    TRIJARDY XR
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    12.5MG;2.5MG;1GM
    2020-01-27
    212614
    TRIJARDY XR
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    5MG;2.5MG;1GM
    2020-01-27
    212614
    TRIJARDY XR
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 212614

    Looking for FDA Orange Book APPLICATION 212614 4

    19

    Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE, with a corresponding application number 212614.

    Regulatory Information RX

    With a dosage strength 25MG;5MG;1GM

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2020-01-27

    18

    Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE, with a corresponding application number 212614.

    Regulatory Information RX

    With a dosage strength 10MG;5MG;1GM

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2020-01-27

    17

    Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE, with a corresponding application number 212614.

    Regulatory Information RX

    With a dosage strength 12.5MG;2.5MG;1GM

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2020-01-27

    16

    Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE, with a corresponding application number 212614.

    Regulatory Information RX

    With a dosage strength 5MG;2.5MG;1GM

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2020-01-27

    Post Enquiry
    POST ENQUIRY